Rx Only Tablet • Beta blocker
✓ Medically Reviewed Monograph

Carvedilol

Also known as / Synonyms: Carvedilol, Non-selective beta blocker with alpha-1 blocking activity

Non-selective beta and alpha-1 blocker improving survival in heart failure and reducing high blood pressure.

Medically reviewed by Dr. Lisa Matthews, PharmD BCPS · Clinical Pharmacist
Written by 4mg Clinical Pharmacology Team Last reviewed ✓ Clinically Verified
📋

Clinical Snapshot & Specifications

Generic Name: Carvedilol
Active Ingredient: Carvedilol
Dosage Form: Tablet
Available Strengths: 3.125 mg, 6.25 mg, 12.5 mg, 25 mg tablets
Prescription Status: Prescription only (Schedule H / verified)
Approved Routes:
Oral
Popular Verified Brands:
Carca Coreg Cardivas Carvil Carloc (India)
Regulatory Standards: CDSCO approved; Schedule H prescription medicine. Core cardiovascular guideline-directed medical therapy (GDMT) drug.
🎯

Approved Indications & Medical Uses

  • Mild to severe chronic heart failure of ischemic or cardiomyopathic origin (NYHA Class II-IV) as GDMT.
  • Left ventricular dysfunction following acute myocardial infarction (LVEF <= 40%).
  • Essential hypertension (alone or with other antihypertensives).
🚫

Contraindications (Do Not Use If…)

  • Severe chronic heart failure requiring IV inotropic therapy.
  • Bronchial asthma or severe chronic obstructive pulmonary disease (COPD) with bronchospasm.
  • Second- or third-degree AV block (unless pacemaker placed).
  • Severe bradycardia (< 50 bpm) or sick sinus syndrome.
  • Cardiogenic shock or severe hypotension (systolic BP < 85 mmHg).
  • Severe hepatic impairment.
🛡️

Important Clinical Precautions & Warnings

  • Do not discontinue abruptly; abrupt cessation can cause acute exacerbation of angina, myocardial infarction, or ventricular arrhythmias.
  • Postural hypotension and dizziness: start low, titrate slowly every 2 weeks, and administer with food.
  • Worsening heart failure or fluid retention: monitor daily weights during titration; adjust diuretic doses.
  • Masks hypoglycemia signs: suppresses tachycardia in diabetic patients; tremors and diaphoresis may persist.
  • Peripheral vascular disease: may aggravate symptoms of arterial insufficiency.

Special Populations (Paediatric & Geriatric Care)

Pediatric: Safety and efficacy in children < 18 years have not been established. Elderly: Heightened sensitivity to postural hypotension and bradycardia; monitor blood pressure and pulse.

⚡

Side Effects & Adverse Reactions

ℹ️ Common Side Effects (Usually Mild)

Dizziness, fatigue, hypotension, bradycardia, fluid overload/peripheral edema, weight gain, diarrhea, and hyperglycemia in diabetics.

🚨 Serious Side Effects — Seek Urgent Medical Care

Severe bradycardia, complete heart block, acute cardiogenic shock, bronchospasm in susceptible patients, and severe syncope.

Action: Discontinue medication and seek immediate medical attention or call emergency services if any serious symptom occurs.

🔄

Drug, Food & Substance Interactions

  • Calcium channel blockers (verapamil, diltiazem): profound bradycardia and conduction abnormalities.
  • Digoxin: increased digoxin plasma levels and enhanced AV nodal slowing.
  • Insulin and oral antidiabetics: potentiates hypoglycemia and masks autonomic symptoms.
  • CYP2D6 inhibitors (fluoxetine, paroxetine): increased carvedilol blood concentrations.
  • Clonidine: concurrent discontinuation can cause severe rebound hypertension.
🤰

Pregnancy & Lactation Clinical Safety

Pregnancy Safety:

Use with caution — see notes

Beta-blockers can cause decreased placental perfusion, intrauterine growth restriction, neonatal bradycardia, and hypoglycemia. Use only if clearly required.

Lactation & Breastfeeding:

Use with caution — see notes

Excretion in human milk is likely; monitor infant for bradycardia and hypotension or consider alternative therapy.

📦

Storage, Administration & Overdose Protocol

🌡️ Recommended Storage:

Store below 30°C in moisture-proof packaging. Protect from direct sunlight.

⏱️ Missed Dose Protocol:

Take twice daily with food to slow absorption and reduce orthostatic dizziness. If missed, take as soon as remembered unless within 4 hours of next dose.

📚

Clinical Sources & Regulatory References

Statutory drug monograph citations and regulatory databases consulted for clinical synthesis.

Every clinical monograph on 4mg.in is continuously cross-referenced against official pharmacopoeias, national formulary compendia, and statutory regulatory filings to guarantee therapeutic precision:

🏛️ CDSCO (Govt. of India)

Central Drugs Standard Control Organisation, Ministry of Health and Family Welfare. Evaluated for approved indications, Schedule H/H1 status, and National List of Essential Medicines (NLEM).

CDSCO Official Portal →
🇺🇸 U.S. FDA / DailyMed

U.S. Food and Drug Administration Approved Prescribing Information, Package Inserts, and Pharmacovigilance Black Box Warnings repository via NLM DailyMed.

Search FDA Labels on DailyMed →
🌐 World Health Organization

WHO Model List of Essential Medicines (23rd List) and WHO Collaborating Centre for Drug Statistics Methodology (Anatomical Therapeutic Chemical - ATC / DDD Index).

WHO Essential Medicines Registry →
🔬 PubMed / NLM

National Center for Biotechnology Information (NCBI). Peer-reviewed clinical trials, bioavailability investigations, and Cochrane systematic reviews.

Query PubMed Studies for Carvedilol →
Suggested Monograph Citation:

4mg Clinical Pharmacology Team. Carvedilol Monograph: Uses, Dosage, Contraindications & Interactions. Medically reviewed by licensed clinical editors. 4mg.in, 2026. Available at: https://4mg.in/medicines/carvedilol/

🛡️
Clinical & Legal Disclaimer: The clinical monographs and drug information published on 4mg.in are strictly intended for educational, clinical reference, and informational utility. They do not constitute personalized medical advice, diagnosis, or treatment regimens. Always seek the advice of a registered physician or licensed pharmacist regarding specific clinical conditions, prescription dosages, and potential contraindications. Review our comprehensive Editorial & Clinical Fact-Checking Policy.